187 Reduction of insulin levels with diazoxide Diazoxide is a nondiuretic benzothiadiazine that has an antihypertensive effect and produces hyperglycemia via lowering insulin levels by activation of ATP-sensitive K + -channels, which have a key function in the control of insulin release
A direct phase 3 study is comparing retatrutide with tirzepatide, but complete results are not yet available
The mixed reviews for Precision Peptide Co suggest inconsistency may be an issue, though the sample size of public reviews is limited enough that definitive conclusions are premature
Porokhovnik LN, cape BM, yaeo A, Chudakova YuM, Ershova ES, Veiko NN, Gorbachevskaya NL, Mamokhina U, Sorokin A, Basova AY, Lapshin MS, Izhevskaya VL, Kostyuk SV (2023) Association of NEF2L2 Rs35652124 polymorphism with Nrf2 induction and genotoxic stress biomarkers in autism
Vujii et al., 1992)